David Brey, MD
Rheumatology · Owensboro, KYNPI 1114962362
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 93 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by Amgen at 33.9% of the total. That places this record below the midpoint for rheumatology clinicians in KY, where the typical reported total is $2,001.
Across 93 payments — averaging $17.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$550
- AbbVie$280
- E.r. Squibb & Sons, L.L.C.$184
- Johnson & Johnson$180
- UCB, Inc.$73
- Aurinia Pharma U.S., Inc.$71
- plus $288 from 8 others
What the payments were for
- Food & beverage$1,625100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 34 | $550 |
| AbbVie | 15 | $280 |
| E.r. Squibb & Sons, L.L.C. | 10 | $184 |
| Johnson & Johnson | 13 | $180 |
| UCB, Inc. | 3 | $73 |
| Aurinia Pharma U.S., Inc. | 3 | $71 |
| AstraZeneca(2 entities) | 3 | $69 |
| Bristol Myers Squibb | 3 | $55 |
| GSK | 2 | $35 |
| Mallinckrodt Hospital Products Inc. | 1 | $35 |
| Lilly USA, LLC | 2 | $33 |
| Pfizer | 2 | $32 |
| Novartis | 1 | $16 |
| Radius Health, Inc. | 1 | $12 |
How this compares
$1,625 in reported general payments places this provider in the 40th percentile of 81 rheumatology providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydroxychloroquine Sulfate | 93 | $1,142 |
| Prednisone | 64 | $253 |
| Duloxetine Hcl | 25 | $252 |
| MethotrexateMethotrexate Sodium | 25 | $206 |
| Gabapentin | 20 | $153 |
| Tramadol Hcl | 15 | $116 |
| Meloxicam | 15 | $25 |
| Omeprazole | 14 | $17 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in Owensboro
- Asad FraserBowling Green$355K
- Rebecca CallisFlorence$272K
- Gary CrumpLouisville$176K
- Benjamin BooneLouisville$80K
- Jacquelyn SmithLouisville$63K
- Neha PansuriaBowling Green$39K
- Timothy LoneskySomerset$32K
- Mansoor AhmedRichmond$29K
- Liza VargheseCrestview Hills$29K
- Lisa JuneLouisville$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.